Security
Axe Compute Inc. Common Stock · AGPU
AGPUNASDAQCommon stockCurrentCIK 1446159Updated Oct 6, 2026
Name history
Predictive Oncology Inc. · through Dec 11, 2025Precision Therapeutics Inc. · through Jun 4, 2019Skyline Medical Inc. · through Feb 6, 2018BioDrain Medical, Inc. · through Aug 7, 2013
AGPU price & chart
Loading TradingView…
NASDAQ:AGPU on TradingView ↗About the company
We are a knowledge-driven company focused on applying artificial intelligence (“AI”) to support the discovery and development of optimal cancer therapies, which can ultimately lead to more effective treatments and improved patient outcomes. We use AI and our proprietary biobank of 150,000 tumor samples, categorized by tumor type, to provide actionable insights about drug compounds to improve the drug discovery process and increase the probability of drug compound success. We also create and develop tumor-specific 3D cell culture models mimicking the physiological environment of human tissue, enabling better-informed decision-making during drug development. Our suite of solutions supports oncology drug development from early discovery to clinical trials.
In the news
Axe Compute 成功簽下一份為期五年、總值 15 億美元的專屬 AI 基礎設施合約，令 2026 年的已簽約合約總值超越 30 億美元 ↗
Recent filings
4 filing
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets
Items 1.01, 2.01, 9.01
4 filing
Other Events
Items 8.01, 9.01
Show 5 more recent filings
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
424B3 filing
EFFECT filing
Other Events
Items 8.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 52,888,346Source | 4,972,517Source | 14,417,249Source | 25,734,644Source |
| Property, Plant and Equipment, NetUSD | 223,128Source | 369,470Source | 1,233,910Source | 1,833,255Source |
| GoodwillUSD | — | — | — | 0Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | 210,113Source | 252,457Source | 253,865Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 10,790,850Source | 734,673Source | 8,728,660Source | 22,071,523Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 32,120Source | 745,566Source | 333,697Source | 331,196Source |
| Inventory, NetUSD | — | 385,728Source | 494,374Source | 430,493Source |
| Assets, CurrentUSD | 42,769,947Source | 2,225,918Source | 10,078,431Source | 23,360,013Source |
| Prepaid Expense and Other Assets, CurrentUSD | 280,904Source | 306,301Source | 521,700Source | 526,801Source |
| Operating Lease, Right-of-Use AssetUSD | 1,487,703Source | 2,064,507Source | 2,728,355Source | 211,893Source |
| Other Assets, NoncurrentUSD | 148,887Source | 102,509Source | 124,096Source | 75,618Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 5,171,391Source | 5,175,127Source | 6,145,469Source | 3,968,752Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 40,832Source | 66,670Source | 40,629Source | 787,627Source |
| Additional Paid in CapitalUSD | 461,196,805Source | 180,156,199Source | 175,992,242Source | 174,755,389Source |
| Retained Earnings (Accumulated Deficit)USD | -413,521,474Source | -180,426,271Source | -167,761,883Source | -153,777,916Source |
| Stockholders' Equity Attributable to ParentUSD | 47,716,955Source | -202,610Source | 8,271,780Source | 21,765,892Source |
| Liabilities and EquityUSD | 52,888,346Source | 4,972,517Source | 14,417,249Source | 25,734,644Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 4,266,896Source | 3,593,401Source | 3,951,031Source | 3,882,670Source |
| Operating Lease, Liability, CurrentUSD | 653,743Source | 572,739Source | 517,427Source | 94,237Source |
| Accounts Payable, CurrentUSD | 1,840,608Source | 1,142,919Source | 1,342,027Source | 943,452Source |
| Operating Lease, Liability, NoncurrentUSD | 904,495Source | 1,558,239Source | 2,188,979Source | 86,082Source |
| Other Liabilities, NoncurrentUSD | — | 23,487Source | 5,459Source | 0Source |
| Additional Financial Items | ||||
| Accounts Receivable, after Allowance for Credit LossUSD | — | — | 333,697Source | 331,196Source |
| Accrued Liabilities, CurrentUSD | 1,520,518Source | 1,407,987Source | 1,631,702Source | 2,229,075Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 129,038Source | 162,079Source | 739,316Source | 1,313,075Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 1,032,515Source | 1,118Source | 2,038Source | 166,312Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -2,034Source | 467,925Source | 2,501Source | -23,000Source |
| Increase (Decrease) in InventoriesUSD | — | -95,075Source | 63,881Source | 42,808Source |
| Increase (Decrease) in Accounts PayableUSD | 1,005,900Source | -191,145Source | 398,575Source | -78,322Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | -13,189,390Source | -12,370,800Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | -302,371Source | -475,697Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 0Source | 9,510Source | 276,352Source | 419,869Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 58,369Source | — | — | — |
| Payments for Repurchase of Common StockUSD | — | 0Source | 1,510Source | 27,654Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | 148,898Source | 6,715,405Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | — | — | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 10,056,177Source | -7,993,987Source | -13,342,863Source | -6,131,092Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 10,790,850Source | — | — | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 8,960Source | 11,466Source | 13,904Source | 3,821Source |
| Income Taxes Paid, NetUSD | 0Source | — | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 16,482,661Source | 1,118Source | 2,038Source | 108,596Source |
| Amortization of Intangible AssetsUSD | — | 26,488Source | 27,426Source | 414,706Source |
| DepreciationUSD | 124,460Source | 135,591Source | 711,890Source | 898,369Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | -52,735,000Source | 1,376Source | 12,457Source | 115,647Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | -903Source | -14,346Source |
| Gain (Loss) on Disposition of Intangible AssetsUSD | 0Source | -4,738Source | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | 0Source | -803Source | — | — |
| General and Administrative ExpenseUSD | 25,924,358Source | 7,419,892Source | 9,428,496Source | 11,110,735Source |
| GoodwillUSD | — | — | — | 0Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | 7,231,093Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | 0Source | 0Source | 3,349,375Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | 0Source | 3,349,375Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -232,853,647Source | -10,860,205Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | -241,556Source | -1,804,183Source | — | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -233,095,203Source | -12,664,388Source | -13,983,967Source | -25,737,634Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -233,095,203Source | -12,664,388Source | -13,983,967Source | -25,737,634Source |
| Operating Costs and ExpensesUSD | 2,147,222Source | 2,851,045Source | 4,127,268Source | 3,798,425Source |
| Operating ExpensesUSD | — | 11,737,150Source | 15,229,530Source | — |
| Operating Lease, ExpenseUSD | 784,674Source | 827,363Source | 892,993Source | 746,590Source |
| Proceeds from Issuance of Common StockUSD | 56,005,986Source | 4,960,562Source | 0Source | 6,507,050Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 125,284Source | 1,623,817Source | 1,780,093Source | 1,505,459Source |
| Unrealized Gain (Loss) on DerivativesUSD | -52,700,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cost of RevenueUSD | 72,622Source | 826,137Source | 634,796Source | 505,107Source |
| Operating Income (Loss)USD | -180,915,715Source | -10,939,470Source | -14,084,233Source | -26,033,652Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | -25,737,634Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -233,095,203Source | -12,664,388Source | -13,983,967Source | -25,737,634Source |
| Earnings Per Share, BasicUSD per share | -13.37Source | -2.32Source | -3.48Source | -0.35Source |
| Total Revenue | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 17,429,861Source | 5,453,632Source | 4,014,848Source | 72,997,987Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 17,429,861Source | 5,453,632Source | 4,014,848Source | 72,997,987Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | — | 26,488Source | 27,426Source | 414,706Source |
| Costs and ExpensesUSD | 28,550,449Source | — | — | — |
| Depreciation, Depletion and Amortization, NonproductionUSD | 129,038Source | 162,079Source | 739,316Source | 1,313,075Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | -52,735,000Source | 1,376Source | 12,457Source | 115,647Source |
| General and Administrative ExpenseUSD | 25,924,358Source | 7,419,892Source | 9,428,496Source | 11,110,735Source |
| Goodwill, Impairment LossUSD | — | — | 0Source | 7,231,093Source |
| Gross ProfitUSD | — | 797,680Source | 1,145,297Source | 1,000,352Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -232,853,647Source | -10,860,205Source | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | -13.36Source | -1.99Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | -241,556Source | -1,804,183Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -233,095,203Source | -12,664,388Source | -13,983,967Source | -25,737,634Source |
| Operating Costs and ExpensesUSD | 2,147,222Source | 2,851,045Source | 4,127,268Source | 3,798,425Source |
| Operating ExpensesUSD | — | 11,737,150Source | 15,229,530Source | — |
| Operating Lease, ExpenseUSD | 784,674Source | 827,363Source | 892,993Source | 746,590Source |
| Research and Development ExpenseUSD | 2,147,222Source | 25,987Source | 188,305Source | 320,320Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | 125,284Source | 1,623,817Source | 1,780,093Source | 1,505,459Source |
| Selling and Marketing ExpenseUSD | 406,247Source | 1,466,213Source | 1,510,861Source | 1,358,907Source |